GLP-1 drugs may not help every form of heart failure, researchers warn
A new commentary argues that GLP-1 receptor agonists' heart failure hospitalization benefit may not apply across all heart failure phenotypes.
A new commentary argues that GLP-1 receptor agonists' heart failure hospitalization benefit may not apply across all heart failure phenotypes.
A new commentary outlines methodological concerns about a cross-sectional study linking dietary patterns to calcaneal bone quality in Chinese children ...
An Oncotarget commentary calls for consistent evidentiary standards when evaluating possible associations among COVID-19 infection, vaccination and cancer but does ...
A peer-reviewed commentary by Kent Buse and Sarah Hawkes argues that public health institutions should take responsibility for evaluating AI-generated ...
A new commentary cautions that an observed link between preoperative uric acid levels and MRI measures of early Achilles tendon ...
A 2026 commentary finds that published evidence does not definitively resolve whether a reported FGFR1-rearranged acute mast cell leukemia was ...
A new commentary on efgartigimod in generalized myasthenia gravis warns that post-operative myasthenic crisis is too often treated as a ...
When a person develops dementia, an invisible web of spouses, adult children, friends, and neighbors quietly forms around them. Understanding ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine